img

Global Atosiban Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 110 | Industry : Pharma & Healthcare

Publisher : QY | Format : PDF

Global Atosiban Market Research Report 2024

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Injection
Concentrate


Segment by Application


Hospital Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E




By Company


Ferring Pharmaceuticals
Sun Pharma
Shanghai Soho-Yiming Pharmaceuticals
EVER Pharma
Hangzhou Longshine Bio-Tech
Cayman Chemical
Neore Pharmaceutical

Table of Content

1 Atosiban Market Overview
1.1 Product Overview and Scope of Atosiban
1.2 Atosiban Segment by Type
1.2.1 Global Atosiban Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Injection
1.2.3 Concentrate
1.3 Atosiban Segment by Application
1.3.1 Atosiban Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.4 Global Atosiban Market Size Estimates and Forecasts
1.4.1 Global Atosiban Revenue 2016-2027
1.4.2 Global Atosiban Sales 2016-2027
1.4.3 Atosiban Market Size by Region: 2016 Versus 2021 Versus 2027

2 Atosiban Market Competition by Manufacturers
2.1 Global Atosiban Sales Market Share by Manufacturers (2016-2021)
2.2 Global Atosiban Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Atosiban Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Atosiban Manufacturing Sites, Area Served, Product Type
2.5 Atosiban Market Competitive Situation and Trends
2.5.1 Atosiban Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Atosiban Players Market Share by Revenue
2.5.3 Global Atosiban Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Atosiban Retrospective Market Scenario by Region
3.1 Global Atosiban Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Atosiban Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Atosiban Market Facts & Figures by Country
3.3.1 North America Atosiban Sales by Country
3.3.2 North America Atosiban Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Atosiban Market Facts & Figures by Country
3.4.1 Europe Atosiban Sales by Country
3.4.2 Europe Atosiban Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Atosiban Market Facts & Figures by Region
3.5.1 Asia Pacific Atosiban Sales by Region
3.5.2 Asia Pacific Atosiban Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Atosiban Market Facts & Figures by Country
3.6.1 Latin America Atosiban Sales by Country
3.6.2 Latin America Atosiban Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Atosiban Market Facts & Figures by Country
3.7.1 Middle East and Africa Atosiban Sales by Country
3.7.2 Middle East and Africa Atosiban Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Atosiban Historic Market Analysis by Type
4.1 Global Atosiban Sales Market Share by Type (2016-2021)
4.2 Global Atosiban Revenue Market Share by Type (2016-2021)
4.3 Global Atosiban Price by Type (2016-2021)

5 Global Atosiban Historic Market Analysis by Application
5.1 Global Atosiban Sales Market Share by Application (2016-2021)
5.2 Global Atosiban Revenue Market Share by Application (2016-2021)
5.3 Global Atosiban Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Ferring Pharmaceuticals
6.1.1 Ferring Pharmaceuticals Corporation Information
6.1.2 Ferring Pharmaceuticals Description and Business Overview
6.1.3 Ferring Pharmaceuticals Atosiban Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Ferring Pharmaceuticals Product Portfolio
6.1.5 Ferring Pharmaceuticals Recent Developments/Updates
6.2 Sun Pharma
6.2.1 Sun Pharma Corporation Information
6.2.2 Sun Pharma Description and Business Overview
6.2.3 Sun Pharma Atosiban Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sun Pharma Product Portfolio
6.2.5 Sun Pharma Recent Developments/Updates
6.3 Shanghai Soho-Yiming Pharmaceuticals
6.3.1 Shanghai Soho-Yiming Pharmaceuticals Corporation Information
6.3.2 Shanghai Soho-Yiming Pharmaceuticals Description and Business Overview
6.3.3 Shanghai Soho-Yiming Pharmaceuticals Atosiban Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Shanghai Soho-Yiming Pharmaceuticals Product Portfolio
6.3.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments/Updates
6.4 EVER Pharma
6.4.1 EVER Pharma Corporation Information
6.4.2 EVER Pharma Description and Business Overview
6.4.3 EVER Pharma Atosiban Sales, Revenue and Gross Margin (2016-2021)
6.4.4 EVER Pharma Product Portfolio
6.4.5 EVER Pharma Recent Developments/Updates
6.5 Hangzhou Longshine Bio-Tech
6.5.1 Hangzhou Longshine Bio-Tech Corporation Information
6.5.2 Hangzhou Longshine Bio-Tech Description and Business Overview
6.5.3 Hangzhou Longshine Bio-Tech Atosiban Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Hangzhou Longshine Bio-Tech Product Portfolio
6.5.5 Hangzhou Longshine Bio-Tech Recent Developments/Updates
6.6 Cayman Chemical
6.6.1 Cayman Chemical Corporation Information
6.6.2 Cayman Chemical Description and Business Overview
6.6.3 Cayman Chemical Atosiban Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Cayman Chemical Product Portfolio
6.6.5 Cayman Chemical Recent Developments/Updates
6.7 Neore Pharmaceutical
6.6.1 Neore Pharmaceutical Corporation Information
6.6.2 Neore Pharmaceutical Description and Business Overview
6.6.3 Neore Pharmaceutical Atosiban Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Neore Pharmaceutical Product Portfolio
6.7.5 Neore Pharmaceutical Recent Developments/Updates

7 Atosiban Manufacturing Cost Analysis
7.1 Atosiban Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Atosiban
7.4 Atosiban Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Atosiban Distributors List
8.3 Atosiban Customers

9 Atosiban Market Dynamics
9.1 Atosiban Industry Trends
9.2 Atosiban Growth Drivers
9.3 Atosiban Market Challenges
9.4 Atosiban Market Restraints

10 Global Market Forecast
10.1 Atosiban Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Atosiban by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Atosiban by Type (2022-2027)
10.2 Atosiban Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Atosiban by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Atosiban by Application (2022-2027)
10.3 Atosiban Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Atosiban by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Atosiban by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Atosiban Sales (Kg) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Atosiban Sales (Kg) Comparison by Application (2021-2027)
Table 3. Global Atosiban Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Atosiban Covered in This Study
Table 5. Global Atosiban Sales (Kg) of Key Manufacturers (2016-2021)
Table 6. Global Atosiban Sales Share by Manufacturers (2016-2021)
Table 7. Global Atosiban Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Atosiban Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Atosiban Average Price (USD/g) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Atosiban Manufacturing Sites and Area Served
Table 11. Manufacturers Atosiban Product Type
Table 12. Global Atosiban Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Atosiban by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atosiban as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Atosiban Sales by Region (2016-2021) & (Kg)
Table 16. Global Atosiban Sales Market Share by Region (2016-2021)
Table 17. Global Atosiban Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Atosiban Sales by Country (2016-2021) & (Kg)
Table 19. North America Atosiban Sales Market Share by Country (2016-2021)
Table 20. North America Atosiban Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Atosiban Revenue Market Share by Country (2016-2021)
Table 22. Europe Atosiban Sales by Country (2016-2021) & (Kg)
Table 23. Europe Atosiban Sales Market Share by Country (2016-2021)
Table 24. Europe Atosiban Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Atosiban Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Atosiban Sales by Region (2016-2021) & (Kg)
Table 27. Asia Pacific Atosiban Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Atosiban Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Atosiban Revenue Market Share by Region (2016-2021)
Table 30. Latin America Atosiban Sales by Country (2016-2021) & (Kg)
Table 31. Latin America Atosiban Sales Market Share by Country (2016-2021)
Table 32. Latin America Atosiban Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Atosiban Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Atosiban Sales by Country (2016-2021) & (Kg)
Table 35. Middle East and Africa Atosiban Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Atosiban Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Atosiban Revenue Market Share by Country (2016-2021)
Table 38. Global Atosiban Sales (Kg) by Type (2016-2021)
Table 39. Global Atosiban Sales Market Share by Type (2016-2021)
Table 40. Global Atosiban Revenue (Million US$) by Type (2016-2021)
Table 41. Global Atosiban Revenue Share by Type (2016-2021)
Table 42. Global Atosiban Price (USD/g) by Type (2016-2021)
Table 43. Global Atosiban Sales (Kg) by Application (2016-2021)
Table 44. Global Atosiban Sales Market Share by Application (2016-2021)
Table 45. Global Atosiban Revenue (Million US$) by Application (2016-2021)
Table 46. Global Atosiban Revenue Share by Application (2016-2021)
Table 47. Global Atosiban Price (USD/g) by Application (2016-2021)
Table 48. Ferring Pharmaceuticals Corporation Information
Table 49. Ferring Pharmaceuticals Description and Business Overview
Table 50. Ferring Pharmaceuticals Atosiban Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 51. Ferring Pharmaceuticals Atosiban Product
Table 52. Ferring Pharmaceuticals Recent Developments/Updates
Table 53. Sun Pharma Corporation Information
Table 54. Sun Pharma Description and Business Overview
Table 55. Sun Pharma Atosiban Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 56. Sun Pharma Atosiban Product
Table 57. Sun Pharma Recent Developments/Updates
Table 58. Shanghai Soho-Yiming Pharmaceuticals Corporation Information
Table 59. Shanghai Soho-Yiming Pharmaceuticals Description and Business Overview
Table 60. Shanghai Soho-Yiming Pharmaceuticals Atosiban Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 61. Shanghai Soho-Yiming Pharmaceuticals Atosiban Product
Table 62. Shanghai Soho-Yiming Pharmaceuticals Recent Developments/Updates
Table 63. EVER Pharma Corporation Information
Table 64. EVER Pharma Description and Business Overview
Table 65. EVER Pharma Atosiban Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 66. EVER Pharma Atosiban Product
Table 67. EVER Pharma Recent Developments/Updates
Table 68. Hangzhou Longshine Bio-Tech Corporation Information
Table 69. Hangzhou Longshine Bio-Tech Description and Business Overview
Table 70. Hangzhou Longshine Bio-Tech Atosiban Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 71. Hangzhou Longshine Bio-Tech Atosiban Product
Table 72. Hangzhou Longshine Bio-Tech Recent Developments/Updates
Table 73. Cayman Chemical Corporation Information
Table 74. Cayman Chemical Description and Business Overview
Table 75. Cayman Chemical Atosiban Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 76. Cayman Chemical Atosiban Product
Table 77. Cayman Chemical Recent Developments/Updates
Table 78. Neore Pharmaceutical Corporation Information
Table 79. Neore Pharmaceutical Description and Business Overview
Table 80. Neore Pharmaceutical Atosiban Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 81. Neore Pharmaceutical Atosiban Product
Table 82. Neore Pharmaceutical Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Atosiban Distributors List
Table 86. Atosiban Customers List
Table 87. Atosiban Market Trends
Table 88. Atosiban Growth Drivers
Table 89. Atosiban Market Restraints
Table 90. Global Atosiban Sales Forecast by Type (2022-2027) & (Kg)
Table 91. Global Atosiban Sales Market Share Forecast by Type (2022-2027)
Table 92. Global Atosiban Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 93. Global Atosiban Revenue Market Share Forecast by Type (2022-2027)
Table 94. Global Atosiban Sales Forecast by Application (2022-2027) & (Kg)
Table 95. Global Atosiban Sales Market Share Forecast by Application (2022-2027)
Table 96. Global Atosiban Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 97. Global Atosiban Revenue Market Share Forecast by Application (2022-2027)
Table 98. Global Atosiban Sales Forecast by Region (2022-2027) & (Kg)
Table 99. Global Atosiban Sales Market Share Forecast by Region (2022-2027)
Table 100. Global Atosiban Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 101. Global Atosiban Revenue Market Share Forecast by Region (2022-2027)
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Atosiban
Figure 2. Global Atosiban Market Share by Type in 2020 & 2027
Figure 3. Injection Product Picture
Figure 4. Concentrate Product Picture
Figure 5. Global Atosiban Market Share by Application in 2020 & 2027
Figure 6. Hospital Pharmacies
Figure 7. Online Pharmacies
Figure 8. Global Atosiban Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Atosiban Market Size 2016-2027 (US$ Million)
Figure 10. Global Atosiban Sales 2016-2027 (Kg)
Figure 11. Global Atosiban Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Atosiban Sales Share by Manufacturers in 2020
Figure 13. Global Atosiban Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Atosiban Players: Market Share by Revenue in 2020
Figure 15. Atosiban Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Atosiban Sales Market Share by Region (2016-2021)
Figure 17. Global Atosiban Sales Market Share by Region in 2020
Figure 18. Global Atosiban Revenue Market Share by Region (2016-2021)
Figure 19. Global Atosiban Revenue Market Share by Region in 2020
Figure 20. U.S. Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. U.A.E Atosiban Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Atosiban by Type (2016-2021)
Figure 45. Sales Market Share of Atosiban by Application (2016-2021)
Figure 46. Sales Market Share of Atosiban by Application in 2020
Figure 47. Revenue Share of Atosiban by Application (2016-2021)
Figure 48. Revenue Share of Atosiban by Application in 2020
Figure 49. Manufacturing Cost Structure of Atosiban
Figure 50. Manufacturing Process Analysis of Atosiban
Figure 51. Atosiban Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed